无并发症晚发型B组链球菌菌血症缩短静脉抗生素疗程
该多中心回顾性队列研究纳入2000至2015年7天至4月龄因无并发症晚发型GBS菌血症住院的775例婴儿,比较缩短(≤8天且无PICC)与延长静脉抗生素疗程的复发率。结果显示缩短疗程组GBS复发率为1.8%,延长组为2.3%,调整后绝对风险差为-0.2%(95%CI:-3.0%至2.5%)。
要点
- 无并发症晚发型GBS菌血症婴儿中21%接受了缩短静脉抗生素疗程。
- 缩短疗程组GBS复发率1.8%,与延长疗程组2.3%相比无显著差异。
- 缩短疗程使用率在各医院间差异大(范围0%-67%)。
核心结论
- 无并发症晚发型GBS菌血症婴儿中缩短静脉抗生素疗程与延长疗程相比,GBS疾病复发率低且无显著差异。
研究设计与样本
- 多中心回顾性队列研究,纳入2000至2015年Pediatric Health Information System数据库中7天至4月龄因GBS菌血症住院的婴儿。
- 暴露定义为缩短静脉抗生素治疗,即指数GBS就诊后住院时间≤8天出院且无PICC收费。
- 主要结局为出生后第一年因GBS菌血症、脑膜炎或骨髓炎再住院。
- 采用倾向性调整的逆概率加权回归模型分析结局。
主要发现
- 775例无并发症晚发型GBS菌血症婴儿中,612例(79%)接受延长静脉疗程,163例(21%)接受缩短疗程。
- 缩短疗程使用率因医院而异(范围0%-67%;标准差20%)。
- 缩短疗程组3例(1.8%)发生GBS复发,延长疗程组14例(2.3%)发生复发(调整后绝对风险差:-0.2%;95%CI:-3.0%至2.5%)。
关键数值与推荐
- 指南推荐无并发症晚发型GBS菌血症婴儿接受10天静脉抗生素疗程。
- 缩短静脉抗生素疗程定义为住院时间≤8天出院且无PICC收费。
- 主要结局为出生后第一年GBS菌血症、脑膜炎或骨髓炎再住院。
临床怎么用
- 对于无并发症晚发型GBS菌血症婴儿,可考虑缩短静脉抗生素疗程以减少PICC相关风险。
- 缩短疗程后需关注出生后第一年GBS复发风险。
局限性
- 回顾性队列研究设计可能存在残余混杂。
- 缩短疗程使用率在各医院间差异大,可能影响结果外推。
- 未报告关于抗生素具体种类、剂量及疗程天数的详细信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: : media-1vid110.1542/5804909691001PEDS-VA_2018-0345Video Abstract BACKGROUND: Guidelines recommend a prolonged course (10 days) of intravenous (IV) antibiotic therapy for infants with uncomplicated, late-onset group B Streptococcus (GBS) bacteremia. Our objective was to determine the frequency with which shorter IV antibiotic courses are used and to compare rates of GBS disease recurrence between prolonged and shortened IV antibiotic courses. METHODS: We performed a multicenter retrospective cohort study of infants aged 7 days to 4 months who were admitted to children's hospitals in the Pediatric Health Information System database from 2000 to 2015 with GBS bacteremia. The exposure was shortened IV antibiotic therapy, defined as discharge from the index GBS visit after a length of stay of ≤8 days without a peripherally inserted central catheter charge. The primary outcome was readmission for GBS bacteremia, meningitis, or osteomyelitis in the first year of life. Outcomes were analyzed by using propensity-adjusted, inverse probability-weighted regression models. RESULTS: Of 775 infants who were diagnosed with uncomplicated, late-onset GBS bacteremia, 612 (79%) received a prolonged IV course of antibiotic therapy, and 163 (21%) received a shortened course. Rates of treatment with shortened IV courses varied by hospital (range: 0%-67%; SD: 20%). Three patients (1.8%) in the shortened IV duration group experienced GBS recurrence, compared with 14 patients (2.3%) in the prolonged IV duration group (adjusted absolute risk difference: -0.2%; 95% confidence interval: -3.0% to 2.5%). CONCLUSIONS: Shortened IV antibiotic courses are prescribed among infants with uncomplicated, late-onset GBS bacteremia, with low rates of disease recurrence and treatment failure.
引用
- Coon ER, Srivastava R, Stoddard G, et al. Shortened IV Antibiotic Course for Uncomplicated, Late-Onset Group B Streptococcal Bacteremia. Pediatrics. 2018. PMID: 30309887. doi:10.1542/peds.2018-0345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。